Professional Evaluation, Inc. | Medical Programs | Complex Lipid Management

Complex Lipid Management

Diabetes Management

Health Disparities

Lipidology

In the pipeline:

University of Chicago
Pritzker School of Medicine
Self-Assessment Program
(3Q/2008)

Cancer Management
(3-4Q/2008)
Breast Cancer
GI Tract Cancer
Lung Cancer
Prostate Cancer

Effective Medical
Management
(4Q/2008)
A New Web-based
Interactive Program
Management of
Type 2 Diabetes: Patient
Management Problems
(4Q/2008)

Educational Objectives

Recognize the role of rosuvastatin and other approved statins
in the management of dyslipidemias.

Understand the comparative pharmacokinetics of rosuvastatin
and other approved statins.

Assess global CHD risk factors and genetic disorders.

Understand the role of inflammatory markers in CHD risk.

Subject Content

Safety, efficacy and pharmacokinetics of rosuvastatin.

Mechanism of action of emerging therapy for dyslipidemias.

Role of inflammatory markers in dyslipidemias.

Global risk assessment.

Genetic disorders.

This edition is for information and study purposes only as the
CME credits have expired.

Back to Complex Lipid Management

$75

$90